MRX vs SNEX: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
MRX and SNEX are similarly sized, but MRX trades noticeably cheaper on forward earnings (11.15x vs 17.27x): the market is paying up for SNEX's profile and pricing MRX more conservatively, or for faster growth. Which you prefer comes down to the drivers you believe, and whether adding either over-concentrates what you already own.
MRX vs SNEX: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | MRX | SNEX | What it tells you |
|---|---|---|---|
| Forward P/E | 11.15 | 17.27 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 14.75 | 20.53 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | -0.09 | 0.66 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 86% of range | 69% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 3.72 | 3.36 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: MRX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how MRX and SNEX affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MRX and SNEX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MRX and SNEX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Marex Group plc (MRX) do?
Marex Group plc operates a diversified global financial services platform that sits between clients and the world's energy, metals, and commodities markets. Its main activities are clearing (handling post-trade processing and holding client balances), agency and execution (matching buyers and sellers and providing price discovery), market making, and hedging and investment solutions such as structured notes. The company also runs technology platforms including Neon (trading, risk, and data) and has grown rapidly through both organic expansion and acquisitions since incorporating in 2005.
What does StoneX Group (SNEX) do?
StoneX Group Inc. is a New York-headquartered financial-services firm that acts as a middleman between clients and the world's financial and commodity markets. It serves more than 54,000 commercial, institutional, and global-payments clients plus over 400,000 retail accounts across roughly 80 offices on five continents, organizing its work into four segments: Commercial (agricultural, energy, and metals hedging), Institutional (securities, futures, FX, and prime services), Retail (self-directed trading brands), and Global Payments (cross-border money movement into hard-to-reach currencies). Because much of what StoneX does is regulated brokerage, clearing, and market-making, the company operates as a holding company over many licensed subsidiaries. A defining recent move was the roughly $900 million acquisition of futures broker R.J. O'Brien, which closed on July 31, 2025 and made StoneX the largest non-bank futures commission merchant in the United States, adding tens of thousands of clients and billions in client float.
MRX vs SNEX: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- MRX drivers: Volatility-driven trading volumes; Clearing scale and client balances.
- SNEX drivers: Scale from the R.J. O'Brien deal; Interest income on client float.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Marex's earnings are cyclical and depend heavily on client trading volumes and market volatility, which can fall sharply in quiet markets and compress commissions. For SNEX, stoneX operates in a low-margin, capital-intensive, and highly regulated industry where a single operational, credit, or compliance failure at any of its many subsidiaries can be costly.
MRX or SNEX: which should you pick?
MRX vs SNEX: the full fundamentals
MRX. Marex posted record Q1 2026 revenue of ~$692m (up ~48% year over year) with adjusted profit before tax of ~$153m and an adjusted margin near 22%. The stock trades at roughly 15 times trailing earnings and about 13 times forward estimates, a valuation that reflects strong recent growth balanced against the cyclical nature of brokerage earnings. A quarterly dividend, raised to ~$0.16 per share, adds a modest income component.
SNEX. StoneX posted record fiscal 2025 results, with operating revenues around $4.1 billion and net income near $306 million on diluted EPS of about $5.89. Note the revenue distinction: as a commodities and financial intermediary the firm also reports tens of billions in gross transactional revenue that is largely pass-through cost, so operating and net operating revenues are the more meaningful figures. At roughly $100 to $110 per share the stock trades around 20 times earnings, a valuation in line with a profitable, cyclical financials name.
Headline figures (approximate, July 2026): MRX shows revenue (ttm) ~$3.3B, net income (ttm) ~$334M, eps (ttm) ~$4.66, market cap ~$4.8B; SNEX shows operating revenues (fy2025) ~$4.1B (up ~20%), net operating revenues (fy2025) ~$2.05B, net income (fy2025) ~$306M (up ~17%), diluted eps (fy2025) ~$5.89.
The bottom line: MRX vs SNEX
MRX and SNEX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MRX and SNEX exposure against your real portfolio. It is not an investment adviser.
Wondering how MRX or SNEX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Marex Group plc with AI
Connect the broker you already use and ask Walnut's AI how MRX fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between MRX and SNEX?
+
Marex Group plc operates a diversified global financial services platform that sits between clients and the world's energy, metals, and commodities markets. StoneX Group Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is MRX or SNEX the better stock?
+
Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, MRX or SNEX?
+
On forward P/E (as of August 2026), MRX trades at 11.15x and SNEX at 17.27x, so MRX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both MRX and SNEX?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of MRX vs SNEX?
+
MRX: Marex's earnings are cyclical and depend heavily on client trading volumes and market volatility, which can fall sharply in quiet markets and compress commissions. A meaningful share of profit comes from net interest income on client balances, so lower interest rates would reduce a high-margin revenue stream. The commission and clearing businesses carry counterparty, credit, and operational risk, and a large default or a risk-management failure could cause outsized losses. Rapid acquisition-led growth adds integration and execution risk, and the firm operates in a heavily regulated, capital-intensive industry across multiple jurisdictions. A planned redomiciling and ongoing structural changes add complexity that investors weigh alongside the growth. SNEX: StoneX operates in a low-margin, capital-intensive, and highly regulated industry where a single operational, credit, or compliance failure at any of its many subsidiaries can be costly. Earnings are cyclical and depend on volatility, trading volumes, and interest rates, so a calm market or falling rates can pressure results. The acquisition-heavy strategy carries integration and leverage risk, and the RJO deal added debt and execution demands. As an intermediary the firm is exposed to counterparty and client-credit risk, and its very large gross-revenue figures can obscure the thinner underlying economics, which makes the stock prone to sharp swings, as its wide 52-week trading range shows.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell MRX or SNEX; figures are approximate and dated (as of August 2026). Verify current data before investing.